1. Home
  2. LFMD vs EMBC Comparison

LFMD vs EMBC Comparison

Compare LFMD & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • EMBC
  • Stock Information
  • Founded
  • LFMD 1994
  • EMBC 1924
  • Country
  • LFMD United States
  • EMBC United States
  • Employees
  • LFMD N/A
  • EMBC N/A
  • Industry
  • LFMD Medical/Nursing Services
  • EMBC Medical/Dental Instruments
  • Sector
  • LFMD Health Care
  • EMBC Health Care
  • Exchange
  • LFMD Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • LFMD 619.0M
  • EMBC 726.8M
  • IPO Year
  • LFMD N/A
  • EMBC N/A
  • Fundamental
  • Price
  • LFMD $11.26
  • EMBC $10.39
  • Analyst Decision
  • LFMD Strong Buy
  • EMBC Hold
  • Analyst Count
  • LFMD 5
  • EMBC 3
  • Target Price
  • LFMD $12.20
  • EMBC $17.00
  • AVG Volume (30 Days)
  • LFMD 1.9M
  • EMBC 688.2K
  • Earning Date
  • LFMD 08-06-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • LFMD N/A
  • EMBC 5.72%
  • EPS Growth
  • LFMD N/A
  • EMBC N/A
  • EPS
  • LFMD N/A
  • EMBC 0.89
  • Revenue
  • LFMD $234,007,330.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • LFMD $29.80
  • EMBC N/A
  • Revenue Next Year
  • LFMD $18.03
  • EMBC N/A
  • P/E Ratio
  • LFMD N/A
  • EMBC $11.75
  • Revenue Growth
  • LFMD 43.07
  • EMBC N/A
  • 52 Week Low
  • LFMD $3.99
  • EMBC $9.20
  • 52 Week High
  • LFMD $15.84
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 39.59
  • EMBC 50.88
  • Support Level
  • LFMD $11.63
  • EMBC $9.97
  • Resistance Level
  • LFMD $14.43
  • EMBC $10.87
  • Average True Range (ATR)
  • LFMD 0.83
  • EMBC 0.45
  • MACD
  • LFMD -0.39
  • EMBC 0.14
  • Stochastic Oscillator
  • LFMD 0.76
  • EMBC 71.47

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: